Role of radiation therapy in the management of locally advanced pancreatic cancer

Journal of Clinical Oncology

Volumn 30, Issue 13, 2012, Pages 1564-1565

  Aref, Amr ^a   Berri, Richard ^a  

^a Van Elslander Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; CANCER RADIOTHERAPY; CANCER SURGERY; DISEASE COURSE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LETTER; LOCALLY ADVANCED PANCREATIC CANCER; OVERALL SURVIVAL; PANCREAS CANCER; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; TREATMENT INDICATION; TUMOR VOLUME; ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; FEMALE; GENETICS; MALE; NOTE; PANCREAS TUMOR;

ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE; SMAD4 PROTEIN;

ADENOCARCINOMA; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, ADENOSQUAMOUS; DEOXYCYTIDINE; FEMALE; HUMANS; MALE; PANCREATIC NEOPLASMS; SMAD4 PROTEIN;

EID: 84862984709     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.40.8674     Document Type: Letter

References (11)

1. Loehrer PJ Sr, Feng Y, Cardenes H, et al: Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: An Eastern Cooperative Oncology Group trial. J Clin Oncol 29:4105-4112, 2011
2. Philip PA: Locally advanced pancreatic cancer: Where should we go from here? J Clin Oncol 29:4066-4068, 2011
3. Iacobuzio-Donahue CA, Fu B, Yachida S, et al: DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. J Clin Oncol 27:1806-1813, 2009
4. Tepper J, Nardi G, Sutt H: Carcinoma of the pancreas: Review of MGH experience from 1963 to 1973 - Analysis of surgical failure and implications for radiation therapy. Cancer 37:1519-1524, 1976
5. Gudjonsson B: Cancer of the pancreas: 50 years of surgery. Cancer 60:2284-2303, 1987
6. Stokes JB, Nolan NJ, Stelow EB, et al: Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer. Ann Surg Oncol 18:619-627, 2011
7. White RR, Xie HB, Gottfried MR, et al: Significance of histological response to preoperative chemoradiotherapy for pancreatic cancer. Ann Surg Oncol 12: 214-221, 2005 (Pubitemid 40568908)
8. Le Scodan R, Mornex F, Partensky C, et al: Histopathological response to preoperative chemoradiation for resectable pancreatic adenocarcinoma: The French phase II FFCD 9704-SFRO trial. Am J Clin Oncol 31:545-552, 2008
9. Talamonti MS, SmallWJr, Mulcahy MF, et al: A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma. Ann Surg Oncol 13:150-158, 2006
10. Crane CH, Varadhachary GR, Yordy JS, et al: Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: Correlation of Smad4(Dpc4) immunostaining with pattern of disease progression. J Clin Oncol 29:3037-3043, 2011
11. Ben-Josef E, Griffith K, Francis IR, et al: Phase I radiation dose-escalation trial of intensity-modulated radiotherapy (IMRT) with concurrent fixed dose-rate gemcitabine (FDR-G) for unresectable pancreatic cancer. J Clin Oncol 27:226s, 2009 (suppl; abstr 4602)